Loading...

Merck & Co., Inc.

6MK.DEXETRA
HealthcareDrug Manufacturers - General
69.20
-0.30(-0.43%)

Merck & Co., Inc. 6MK.DE Peers

See (6MK.DE) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - General Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
6MK.DE€69.20-0.43%173.8B11.53€6.00+3.84%
LLY.DE€677.00+0.39%641.6B63.15€10.72+0.68%
JNJ.DE€136.16+0.24%327.6B17.35€7.85+3.03%
4AB.DE€167.00-0.12%295B81.46€2.05+3.17%
ZEG.DE€128.10+0.12%198.6B29.45€4.35+2.14%
AMG.DE€254.75-0.16%137B26.62€9.57+3.33%
GIS.DE€98.72+0.84%122.8B23.73€4.16+2.68%
PFE.F€21.00+1.99%119.4B17.65€1.19+6.72%
PFE.DE€21.00+1.82%119.4B17.35€1.21+6.73%
SNW.DE€87.64-0.89%106.8B17.56€4.99+4.48%
Showing 1 to 10 of 15 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

6MK.DE vs LLY.DE Comparison

6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 6MK.DE stands at 173.8B. In comparison, LLY.DE has a market cap of 641.6B. Regarding current trading prices, 6MK.DE is priced at €69.20, while LLY.DE trades at €677.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

6MK.DE currently has a P/E ratio of 11.53, whereas LLY.DE's P/E ratio is 63.15. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to LLY.DE's ROE of +0.77%. Regarding short-term risk, 6MK.DE is more volatile compared to LLY.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 6MK.DE.

Stock Price Comparison

Loading...

Frequently Asked Questions